Visiting CPHI Barcelona?
Schedule a Meet
Product List

Product Listing: Atosiban Impurities

Atosiban is a synthetic peptide used to prevent premature labor. During the manufacturing process of Atosiban, impurities may be formed as byproducts or contaminants. These impurities can affect the quality, safety, and efficacy of the final product. Therefore, it is important to identify and control these impurities to ensure the purity and potency of Atosiban. Various analytical techniques are used to detect and quantify these impurities, and strict regulations are in place to limit their levels in the final product.

Atosiban impurities are unwanted substances that may be present in pharmaceutical formulations containing Atosiban. These impurities can affect the quality, safety, and efficacy of the drug product. It is important to monitor and control the levels of these impurities during the drug development process and throughout the product's shelf life. Analytical methods such as HPLC and GC are commonly used for impurity profiling and characterization. Regular testing and analysis can ensure that Atosiban products meet regulatory standards and are safe for human use.

Atosiban Impurity B CS-EO-01627 Impurities
Atosiban Impurity D CS-EO-01628 Impurities
Atosiban Impurity F CS-EO-01629 Impurities
Atosiban Impurity G CS-EO-01630 Impurities

Other Reference Standards of Atosiban

Atosiban CS-O-00863 API Standards
Atosiban Acetate CS-T-48413 API Standards